NDC 14403-3400 – Liraglutide

Liraglutide 18 mg/3mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC14403-3400

Product details

Brand name
Liraglutide
Generic name
Liraglutide
Labeler
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
ANDA · ANDA215503
Marketed since
December 24, 2024
Listing expires
December 31, 2026
Pharmacologic class
GLP-1 Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Liraglutide →

Package NDC codes (3)

Package NDCDescriptionSince
14403-3400-13 mL in 1 SYRINGE, PLASTIC (14403-3400-1)Jun 21, 2024
14403-3400-22 SYRINGE, PLASTIC in 1 CARTON (14403-3400-2) / 3 mL in 1 SYRINGE, PLASTIC (14403-3400-1)Dec 24, 2024
14403-3400-33 SYRINGE, PLASTIC in 1 CARTON (14403-3400-3) / 3 mL in 1 SYRINGE, PLASTIC (14403-3400-1)Dec 24, 2024

Other Liraglutide products